Sign In
Buy ABSI
$5.94
-0.410 (-6.46%)
At Close: Jun 03, 2026
Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI
08:00am, Monday, 12'th Aug 2024
The collaboration unites Absci's Generative AI Drug Creation Platform with leading oncology experts to co-develop up to six novel cancer therapeutics The collaboration unites Absci's Generative AI Dru
Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships
01:24am, Sunday, 28'th Jul 2024
Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships
Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024
08:00am, Wednesday, 10'th Jul 2024
VANCOUVER, Wash. and NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business up
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Wednesday, 03'rd Jul 2024
VANCOUVER, Wash. and NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced that on July 1, 2024, the company g
Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
08:00am, Tuesday, 28'th May 2024
VANCOUVER, Wash. and NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
07:15am, Thursday, 16'th May 2024
It's no secret that artificial intelligence ( AI ) promises to transform every industry and sector, pharma included. But how do those companies plan to leverage AI, and what will it do for their stoc
Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript
01:30pm, Tuesday, 14'th May 2024
Absci Corporation. (NASDAQ:ABSI ) Q1 2024 Earnings Conference Call May 14, 2024 8:30 AM ET Company Participants Alex Khan – Vice President, Finance and Investor Relations Sean McClain – Founder an
Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
07:30am, Tuesday, 14'th May 2024
Initiated IND-enabling studies for ABS-101 in February Continuing to advance ABS-201 and ABS-301 through preclinical studies VANCOUVER, Wash. and NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Absci Corpo
Absci (ABSI) to Report Q1 Earnings: Here's What to Expect
10:16am, Tuesday, 07'th May 2024
The focus is likely to be on progress on its pipeline candidates when generative AI drug creation company Absci (ABSI) reports first-quarter results.
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
12:11pm, Wednesday, 10'th Apr 2024
Absci Corporation (ABSI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
07:30am, Thursday, 21'st Mar 2024
Initiated IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody Entered into collaboration with AstraZeneca for up to $247M in deal value, plus royalties Strengthened balance
VANCOUVER, Wash., March 01, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI) (“Absci”), a data-first generative AI drug creation company, today announced the closing of its underwritten p
Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?
07:51am, Friday, 01'st Mar 2024
Absci Corporation (ABSI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in
Absci Announces Pricing of Public Offering of Common Stock
10:20pm, Tuesday, 27'th Feb 2024
VANCOUVER, Wash., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI) (“Absci”), a data-first generative AI drug creation company, today announced the pricing of an underwritten pub
Absci Announces Proposed Public Offering of Common Stock
04:01pm, Tuesday, 27'th Feb 2024
VANCOUVER, Wash., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI) (“Absci”), a data-first generative AI drug creation company, announced today that it has commenced an underwrit
